Quality & Regulatory Issues in Biopharmaceutical Facility Design A Perspective from Industry Trends
|
|
- Clifford Watkins
- 6 years ago
- Views:
Transcription
1 Quality & Regulatory Issues in Biopharmaceutical Facility Design A Perspective from Industry Trends Paul Smock, Biotechnology Quality & Technical Consultant Meridian BioGroup LLC The opinions and views of the speaker presented are not necessarily those of Meridian BioGroup or AstraZeneca
2 Flexible Facilities - Business Drivers Enablers for Innovation and Design Quality and Regulatory Considerations Open vs Closed Systems and Layout Closed/Functionally Closed - Overview & Challenge References and Acknowledgements
3 Facilities need to be flexible, multi-product clinical and commercial Build to encompass shifting pipeline and demand scenarios Mixed volumes Smaller markets, personalized medicines, multiple indications Higher titers Campaigned production Segregation is based on time Short changeovers Cleaning validation & clearance between products Concurrent production Segregation by Engineering controls closed systems & space Closed systems allow for concurrent, side-by-side, multi-product
4 Objective Rationale Higher value for the patient Reduced CoGs Reduced time-to-market Higher product quality Lower potential for contamination Conditions can be carefully controlled Lower facility capital costs Simpler floor plan Less HVAC Shorter facility construction and qualification times Reduced area classifications Reduced facility complexity Lower facility operating costs Reduced energy Reduced gowning Reduced EMO Greater operational flexibility Ballroom, disposables and alternative design concepts Process equipment more accessible Process is easier to monitor, troubleshoot, and improve
5 Process design and understanding Simplified/platform design Robust understanding of critical steps and controls Closed Systems Flexible organizations Mindset and skills Communication and KM Advanced controls and testing Automation Reduced testing Data acquisition/analysis Facility & System Design Modularization System design options Multi-product manufacturing Area classification and layout
6 All Stainless Steel Pros Proven technology Possible to integrity test Cons Capital intensive Limited flexibility CIP/SIP adds complexity Hybrid Systems Pros Ability to operate at high pressures Lower operating costs Cons Functionally-closed systems. Connection points must be sanitized. All Single-Use Pros Lower capital costs No cleaning validation Cons Potential breaches Integrity testing problematic Leachables and extractables
7 Pictures: Saint Gobain, Wave Biotech, Bayer, Gemü, Sartorius, GE Health Care, Millipore, Central States Industrial Equipment and Service, Inc.
8 Points to Consider Facility Design and Operation
9
10 Concurrent multi-product process: A facility where different products of the same or different class are manufactured at the same time in parallel More challenging than a campaign scenario where production has been sequenced to allow temporal segregation with effective cleaning and changeover Application of Quality and Scientific Risk Management approaches Special considerations for product class, product compatibility and requirement for product containment Assumptions Shared media/buffer prep, bioreactor, harvest and purification process operations Some use of single use components Validated/Verified cleaning for product contact equipment/parts Enhanced controls for some operations (inoc. prep, final DS filtration) Compatible products requiring no special handling
11 Bioburden Control Strategy Facility Design Room Classifications, Cascades and Flows (QRM based) Functionally Closed Systems, Briefly Exposed Operation, Limited use of Open, Aseptic Operations (Axenic monoculture) Cleaning/Sanitization/Sterilization Engineering and Maintenance Controls Process Monitoring Bioburden/Endotoxin Environmental Monitoring Viral Control Strategy BSE/TSE Controls MCB/WCB/EPCB Preparation/Testing/Specifications EOP Testing/Specifications Viral Clearance Validation Facility Pre/Post Viral Segregation
12 Regulatory Drivers: Bioburden Controlled Biologic Bulk Substance Manufacture US FDA CFRs (GXP) and Guidance documents ISO Eudralex Volume 4, Part II ICH Q9 Annex 2 guided by Annex 1 through application of QRM Principles ICH Q10 PIC/S
13 Application of QRM principles for Product Protection and Cross-Contamination Control (Product Protection Control Strategy) Design and construction to facilitate cleaning, maintenance and operations Minimization of potential cross-contamination and limitation of exposure to (objectionable) microbial contaminants Use and justification of open versus closed processing Containment requirements & controls (GLSP/BL1/BL2) Use of Primary (Physical) vs Secondary (Procedural / Temporal) segregation (See EU Annex 2 (latest revision), Premises and Equipment for detail)
14 Weigh/Dispense, Buffer, Media Prep Segregation Personnel Flow Material Flow Animal vs Non-Animal derived material handling Filtration Point of Preparation or Use Cleanliness Levels, Adjacencies, Cascades ISO or EU Classification assignment/controls DeltaP and directional airflow HVAC supply/return design; use of HVAC sinks between zones Grey space use and flows Process Requirements for Unit Operations Upstream (Host Cell Containing) Harvest (Host Cell removing) Downstream (Non-Host Cell containing) Host cell Type (Mammalian, Bacterial, Other) Low Controlled Bioburden versus Sterile
15 GRADE ISO CLASS EUROPE/ USA FDA (approx.) IN OPERATION MAX # PARTICLES 0.5 µ & LARGER / M 3 MAX # OF VIABLE MICROORGANISMS (CFUs) / M 3 A <1 N/A B C D "9" (at rest) 200
16 Layout Considerations
17 Inoc CC Harv P1 P2 BF Line 1 Open Closed Closed Closed Closed Closed Line 2 Open Closed Closed Closed Closed Closed Individual room
18 Inoc CC Harv P1 P2 BF Line 1 Open Closed Closed Closed Closed Closed Line 2 Open Closed Closed Closed Closed Closed Individual room PIC/S Item 12. Processing steps after harvesting may be carried out in the same production area provided that adequate precautions are taken to prevent cross contamination.
19 Notes: 1. Common harvest filtration and storage equipment assumed. This could be feasible with single-use filters and storage bags. Change over cleaning for stainless steel equipment (e.g. pumps) Cleaning would have to be carefully planned and validated. 2. For basal media. By using a storage bin for this, the media preparation and bioreactor preparation activates can be decoupled. This allows implementation of a variable-volume inoculation scheme for the full scale bioreactor 3. Growth media can be stored in stacked bins. Typical Single Use Bags / Container s Typical Bio-Reactor SS or Single Use Flow Transition Spaces, separate or combined, as appropriate to facility Cell Culture Line 1 Chromatography Line 1 Matls. Matls. Matls. Matls. Final Purification Line 1 Matls. Flow Transition Spaces, separate or combined, as appropriate to facility Materials Note 1 Note 2 Note 3 Materials Personnel Personnel Assumptions: Inoculum transfer takes place as part of the material transfer into the Main Hall. Equipment Waste Common Media Prep. Matls. Matls. Matls. Matls. Matls. Common Buffer Prep Matls. Matls. Equipment Waste CNC Room environment in Main Hall and final Purification Areas. Closed Processes Shared equipment: Buffer Prep, Media Prep, Centrifuge, Harvest, & Clarification Cell Culture Line 2 Chromatography Line 2 Final Purification Line 2 Multiple Concurrent Processing
20 Why, What and How & The Big Challenge
21 Consider More Focus On Designing processes that are closed Verifying that processes are integral Demonstrating effectiveness of sanitization methods to achieve closure Less Focus On Designing and operating highly classified cleanroom environments Monitoring to demonstrate environments meet classification claims Complex gowning and procedures Airlocks Personnel, material, and waste flows that companies should focus on mitigating measures that are most effective and bring the highest value to the patient.
22 Closed System Scheme OUTPUT - Gas Phase exhaust air, vent lines INPUT - Gas Phase Air, CO2, N2, O2, etc. OUTPUT - Gas Phase exhaust air, vent lines Gas Filter Gas Filter INPUT - Liquid Phase media, buffer, ph adj. Liquid Filter Closed System Battery Limits Internal Fittings Closed System INPUT - Liquid Phase pre-sterilized media, pre-filtrated buffer, WFI INPUT - Vapor Phase CIP, Clean Steam INPUT - Liquid Phase Product Equipment Assembly XXX Sample port Instrumentation OUTPUT - Liquid Phase Product OUTPUT - Liquid Phase liquid waste OUTPUT - Liquid Phase steam condensate Closed System Legend Equipment Assembly Streams Connectors or Disconnectors.
23 More complex design Vessel and transfer line can be steamed and sanitized without opening Integrity testing possible Precedent for CNC manufacturing Operations segregation may be diminshed or eliminated May not be flexible!
24 Γ-sterilized Γ-sterilized Γ-sterilized Γ-sterilized Sterile tubing fuser or aseptic connector Design complexity borne by the vendor but end user must qualify. Possibility of leaks (integrity test may not be possible) Bag seams Tubing engagements Peristaltic pump tubing wear or misalignment Flexible; other Quality Issues e.g. E/L
25 NEED PROOF! Functionally-Closed Connection in CNC Open Connection in Grade C What could be in a the environment? Bacteria, mold, virus Cell culture material (from spill) In-Process API from another process Sanitization measures need to be validated
26
27 ISPE Biopharm Process Guide 2013 ISPE Biopharm Baseline Guide Volume 6, 2004 ISPE Biopharm Facility Guide 2013 ISPE Biopharm Single Use Guide 2014
28 Chalk, S., et.al.; Challenging the Cleanroom Paradigm for Biopharmaceutical Manufacturing of bulk Drug Substances, BioPharm. Intl., August, 2011 Chalk, S., et.al.; New Challenges to the Cleanroom Paradigm for Multi-Product Facilities, BioPharm Intl., May 2013
29 Simon Chalk, BioPhorum Operations Group Scott Probst, Bayer Technology Services David Estape, M+W Group, GmbH Ken Green, Pfizer Manufacturing Services Marc Pelletier, CRB Engineers Steve Miller, AstraZeneca- Global Engineering Alison Demarest, Meridian BioGroup
Advancements on implementation of single use technology in vaccine manufacturing
Advancements on implementation of single use technology in vaccine manufacturing October 25 th, 2013 DCVMN Meeting Rio de Janeiro, Brazil Outline Overview of single use products Applications of single
More informationApplication of Single-Use Equipment for Buffer Storage and Distribution in Medium Size mab Production Facility
Reprinted from PHARMACEUTICAL ENGINEERING THE OFFICIAL TECHNICAL MAGAZINE OF ISPE JANUARY/FEBRUARY 2014, VOL 34, NO 1 Copyright ISPE 2014 www.pharmaceuticalengineering.org facilities and equipment Application
More informationDriving Value through Innovation in Biotech Manufacturing. Agenda
Driving Value through Innovation in Biotech Manufacturing Jorg Thommes, PhD Senior Vice President Operations Technology and Innovation Biogen 7 October 2015 Agenda Biopharma Legacy, Trends, & Challenges
More informationGuiding Principles for the implementation of fluid management technologies for modern single use aseptic processing
Guiding Principles for the implementation of fluid management technologies for modern single use aseptic processing Jean-Marc Cappia, Vice President Marketing Fluid Management Technologies Agenda 1. Aseptic
More informationSingle-Use Final Fill: Benefits and Considerations
Single-Use Final Fill: Benefits and Considerations TENDÊNCIAS DE TECNOLOGIAS DE FABRICAÇÃO E ASSÉPTICA DE MEDICAMENTOS Ana Luísa Lampert Cadore Sales Specialist SU & Aseptic Process Solutions ana.cadore@merckgroup.com
More informationValidation of Sterilizing Grade Filters
Validation of Sterilizing Grade Filters Presented by Laura Okhio-Seaman Sartorius Corporation 1 Sterilizing Grade Filters The definition of a sterilizing grade filter is one that will produce a sterile
More informationThe Use of Disposable Technologies in Antibody Manufacturing Processes
The Use of Disposable Technologies in Antibody Manufacturing Processes Tim Matthews and Brad Wolk Process Development Engineering Genentech, Inc. South San Francisco, CA Outline Rationale for using disposable
More informationAnnex A2. Guidance on Process Validation Scheme for Aseptically Processed Products
Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...
More informationA Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody.
A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody. Jeremy M Tong (presenting), Mark S Kettel, Edward M Perry, David J Pain, David M Valentine,
More informationFRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME INTEGRATED PRODUCTION PLATFORMS GMP-COMPLIANT PRODUCTION OF BIOPHARMACEUTICALS
FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME INTEGRATED PRODUCTION PLATFORMS GMP-COMPLIANT PRODUCTION OF BIOPHARMACEUTICALS Close-up of large scale UF/DF control unit conditions and
More informationAseptic Process Validation
Aseptic Process Validation IMB GMP Information Seminar 27 th September 2012 Gerard Sheridan, Inspector Date Insert on Master Slide Slide 1 Overview Guidance Best Practices Common Deficiencies Slide 2 Aseptic
More informationFlexboy 2D Pre-designed Solutions for Storage Best Performance, Assurance of Supply and Closure Integrity for All Process Steps
Storage Best Performance, Assurance of Supply and Closure Integrity for All Process Steps 2 Flexboy 2D Pre-designed Solutions Table Please click on the headline to go to the selected topic Digital Selection
More informationOverview of a sterility assurance program for PET drugs
Coalition for PET Drug Approval Radiopharmaceutical Sciences Council Overview of a sterility assurance program for PET drugs Eric Webster, PETNET Solutions Disclosures Employee of PETNET Solutions, a Siemens
More informationPRAXIS. A publication by Bioengineering AG
PRAXIS A publication by Bioengineering AG Portrait of Rentschler Biotechnologie GmbH, a globally active service company that supports its clients in the development, production, and registration of biopharmaceuticals.
More informationPhEn-602 Notes # 4 J. Manfredi
PhEn-602 Notes # 4 J. Manfredi Spring 2009 1 Basic definitions Clean Room: A room in which the concentration of airborne particles is controlled and contains one or more clean zones Clean Zone: A defined
More informationApplication of Quality Risk Management Tools for Cell Therapy Manufacturing
Application of Quality Risk Management Tools for Cell Therapy Manufacturing 17 th ISCT Annual Meeting May 20, 2011 Jean Stanton Associate Director, Product Quality Management Janssen Supply Chain Conflict/Disclaimer
More informationIsolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite
APV 2008 Basle Conference Basle, Switzerland: May 28 & 29 2008 Isolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite John R. Chester Principal Engineer Global Pharmaceutical
More informationFlexsafe 2D & 3D Pre-Designed Solutions for Storage and Shipping Take Your Facility Into The Future
& 3D Pre-Designed Solutions for Storage and Shipping Take Your Facility Into The Future 2 & 3D Pre-designed Solutions Table of Contents Please click on headline to go to the selected page Back Go to to
More informationThe validation of biological Active Pharmaceutical
This article presents a procedure for the validation of biological API manufacturing processes. It details each step of the procedure for biological processes applications, and covers the regulatory requirements
More informationProcess Robustness & Challenges to Demonstrating Compliance
Process Robustness & Challenges to Demonstrating Compliance Nick Smith Head of Production & TSS 2 nd March 2017 95% Thomas Eldered 5% Management Headcount : 270 3 GMP facilities Cobra s Structure Cobra
More informationThe biopharmaceutical industry
S i n g l e - U s e APPLICATIONS Understanding Particulates in Single-Use Bags Their Relationship to USP Chapter by Michael W. Johnson The biopharmaceutical industry is facing many challenges. Global
More informationStandard Scalable Flexel 3D Bioprocessing Bags
Standard Scalable Flexel 3D Bioprocessing Bags Fluid Management Systems Description Standard Scalable Flexel 3D Bioprocessing Bags are designed for processing and storage of small volume biopharmaceutical
More informationIntegration of Risk Management into Product Strategy and Portfolio. Lori Richter Senior Consultant: QRM and Quality Systems ValSource, LLC
Integration of Risk Management into Product Strategy and Portfolio Lori Richter Senior Consultant: QRM and Quality Systems ValSource, LLC Focus for Today Leveraging ICH Q9 risk management concepts to identify
More informationFlexsafe 3D Pre-Designed Solutions for Storage and Shipping Take Your Facility Into The Future
Flexsafe 3D Pre-Designed Solutions for Storage and Shipping Take Your Facility Into The Future 2 Flexsafe 3D Pre-designed Solutions Table Please click on headline to go to the selected page Digital Selection
More informationAseptic Processing Current Issues & Trends
Aseptic Processing Current Issues & Trends 1 Introduction Richard M. Johnson Member, PDA for 20+ years President & CEO since 2009 Ladies and Gentlemen, I am happy to be here with you. Senhoras e Senhores,
More informationA Journey in Global PUPSIT Implementation with Benchmarking. PDA Midwest Event Oct 5th, 2017 Jeff Gaerke P.E.
A Journey in Global PUPSIT Implementation with Benchmarking PDA Midwest Event Oct 5th, 2017 Jeff Gaerke P.E. Purpose Share learning on ongoing global implementation of PUPSIT for parenteral operations.
More informationTechnical Report No. 61 Steam In Place
Technical Report No. 61 Steam In Place PDA Technical Report No. 61: Steam in Place Task Force Members Authors Kevin Trupp (Task Force Chair), Retired Dave Adams, Baxter Healthcare Corporation Keith E.
More informationFiltration of Cell Culture Growth Media and Process Buffers
Customer Application Brief Bioprocess, Biologicals, & Pharmaceutical Filtration of Cell Culture Growth Media and Process Buffers Introduction Media feeds and process buffers are two universal additives
More informationISPE Baseline Pharmaceutical Engineering Guide for New and Renovated Facilities Volume 2: Oral Solid Dosage Forms (Revision) Executive Summary
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE September/October 2008, Vol. 28 No. 5 This executive summary provides an overview of the second edition of the ISPE Baseline Guide:
More informationXDR Single-Use Bioreactors
DATA SHEET XDR Single-Use Bioreactors Introduction The XDR Single-Use Bioreactor is a fully-integrated system that delivers proven stirred-tank performance across a wide range of cell lines. Single use
More informationSingle-Use Products in BioManufacturing: Innovations Driving the Industry Bioprocess International SUPPLEMENT March 2011 By Eric Langer
Single-Use Products in BioManufacturing: Innovations Driving the Industry Bioprocess International SUPPLEMENT March 2011 By Eric Langer Biopharmaceutical manufacturers and CMOs are continuing to integrate
More informationNew Product Brief PreVAS Single-use Dosing System. Packaging Technology. 3 Disposable Dosing Systems
3 Disposable Dosing Systems New Product Brief PreVAS Single-use Dosing System Packaging Technology Copyright 2010 Bosch Packaging Technology. PreVAS Brochure V3 7-2010. Subject to change without notice.
More informationOctober 10, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852
October 10, 2017 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA 2017 D 2802: Chemistry, Manufacturing, and Controls
More informationGuidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE
Guidance Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and
More informationStandard Flexel 3D bioprocessing bags for Palletank (For Europe, Asia and Latin America)
Standard Flexel 3D bioprocessing bags for Palletank (For Europe, Asia and Latin America) Fluid Management Systems Features Multiple manufacturing sites All connections extensively qualified Full compliance
More informationStandard Flexel 3D bioprocessing bags for Palletank (US and Canada)
Standard Flexel 3D bioprocessing bags for Palletank (US and Canada) Fluid Management Systems Features Multiple manufacturing sites All connections extensively qualified Full compliance with ISO37 Standard
More informationImplementation of Single-Use Systems Benefits and Challenges
Implementation of Single-Use Systems Benefits and Challenges Jerold Martin Sr. VP, Global Scientific Affairs Pall Life Sciences Chairman-Emeritus, BioProcess Systems Alliance (BPSA) This presentation is
More informationBIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE
The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate and/or remove potential viral contaminants. Experience and knowledge in selecting
More informationValidation Study on How to Avoid Microbial Contamination during Pharmaceutical Production
Biocontrol Science, 2015, Vol. 20, No.1, 1 10 Review Validation Study on How to Avoid Microbial Contamination during Pharmaceutical Production HIDEHARU SHINTANI 1-13-27, Kasuga, Bunkyo, Tokyo 112-0003,
More informationThis compilation of the complex
Manufacturing in a Global Marketplace Reference Matrices on Regulations for Classified (Environmentally Controlled) Areas Betty Seawell, William Miele, and Jean Huxsoll The complex world of international
More informationCompounding Aseptic Isolators (CAI) James T Wagner
Compounding Aseptic Isolators (CAI) James T Wagner jimwagner@cenvironment.com Disclaimer "Although I am a member of the USP Sterile Compounding Expert Committee, I am speaking today in my individual capacity
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationWhitepaper. High temperature HEPA filtration. Dr.-Ing. Marc Schmidt, Dr.-Ing. Lothar Gail, Hugo Hemel MSc. Preview
High temperature HEPA filtration Air filtration challenges and answers for dry heat sterilization tunnels Whitepaper Preview Dr.-Ing. Marc Schmidt, Dr.-Ing. Lothar Gail, Hugo Hemel MSc. Air filtration
More informationFiltration in Preparation of Cell Culture Media and Buffers
Filtration in Preparation of Cell Culture Media and Buffers Cell Culture Media and Buffers in Biopharmaceutical Production Cell culture media and process buffers are used in all biopharmaceutical operations.
More informationTom Sulpizio and Jeff Taniguchi, Advanced Minerals Corporation A Member of Imerys 130 Castilian Way, Santa Barbara, CA 93117
ADVANCES IN DISPOSABLE DIATOMITE FILTER AID SYSTEMS FOR CGMP BIOSEPARATIONS Session Pretreatment in Bioseparations AFSS Annual Meeting Valley Forge, PA May 20, 2008 ABSTRACT Tom Sulpizio and Jeff Taniguchi,
More informationMedia Fill A Process Simution. Presented By Shikha Chauhan
Media Fill A Process Simution Presented By Shikha Chauhan 21 CFR 211.113 Validation of Aseptic Processing and Sterilization Process Simulation / Media Fill Filtration Efficacy Sterilization of Equipment,
More informationMicrobiological Cleaning Method Validation
Microbiological Cleaning Method Validation The purpose of cleaning procedures should never be to reduce bioburden to an acceptable level! Fergus O Connell QA Manager Eurofins ams Laboratories www.eurofins.com
More informationDisinfectant Qualification Bacteria, Fungi, Viruses and Atypical Organisms A Step by Step Workshop
Microrite, Inc. brings you this unique advanced course in ; part of Microrite s Step by Step Workshop Series Participate in the only workshop which will guide you through the process of choosing a cost
More informationAmazon FILTRATION SOLUTIONS PHARMACEUTICAL MANUFACTURING
Amazon FILTRATION SOLUTIONS PHARMACEUTICAL MANUFACTURING FILTRATION SOLUTIONS FOR PHARMACEUTICAL MANUFACTURING Delivering quality filtration products As one of Europe s leading manufacturers of process
More informationIntroduction to TFF. Sengyong Lee Ph.D. Professor/ Program Chair Biotechnology/ Biology Ivy Tech Community College Bloomington, Indiana
Introduction to TFF Sengyong Lee Ph.D. Professor/ Program Chair Biotechnology/ Biology Ivy Tech Community College Bloomington, Indiana Main Agenda Biomanufacturing and Filtration Filtration Principles
More informationIn the current competitive biopharmaceutical
Image Courtesy of Sartorius Stedim Biotech single-use Bioreactors for the rapid Production of Preclinical and clinical Biopharmaceuticals Rüdiger Heidemann, Christopher R. Cruz, Paul Wu, Mikal Sherman,
More informationSterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)
Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE CriticalPoint s Sterile Compounding elearning curriculum is written by industry experts and covers both Chapter and
More informationMicrobiological Consideration for Non-Sterile Pharmaceutical
May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control
More informationCurrent Trends in Sterile Manufacturing. by Sterling Kline, RA Director of Project Development Integrated Project Services (IPS)
Current Trends in Sterile Manufacturing by Sterling Kline, RA Director of Project Development Integrated Project Services (IPS) Executive Summary Drug developers go to great lengths to assure that their
More informationsterility assurance Prove the power and your processes
sterility assurance Prove the power and efficacy of your processes sterility assurance programs: an introduction YOUR CHALLENGES Contamination events cost a lot of time and money. Sterility problems can
More informationHot Topics in Drug Product Process Validation: A Reviewer s Perspective
Hot Topics in Drug Product Process Validation: A Reviewer s Perspective Colleen Thomas, Ph.D. Quality Assessment Lead (Acting) FDA/CDER/OPQ/OPF Division of Microbiology Assessment CASSS CMC Strategy Forum
More informationRegulatory perspectives on CQAs, CPPs, and Risk Analyses for Combination Products.
Regulatory perspectives on CQAs, CPPs, and Risk Analyses for Combination Products. 3rd FDA/PQRI Conference on Advancing Product Quality March 22-24, 2017 TRACK #2 Achieving Drug Product Quality: Novel
More informationIs it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS
Is it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS Agenda Annex 1 revision why? Impact of the change on the field Conclusion The Revision
More informationImproving Bioprocessing Productivity Through the Application of Single-Use Protein A Columns
Improving Bioprocessing Productivity Through the Application of Single-Use Protein A Columns By K. John Morrow, Jr. Ph.D. In the last two decades, the bioprocessing industry has confronted the demands
More informationSterifix RELIABLE TECHNOLOGY FOR thermal wastewater
Thermal Wastewater Inactivation AND Sterilisation Sterifix RELIABLE TECHNOLOGY FOR thermal wastewater sterilisation and INActivating EnviroChemie offers intelligent solutions for reliable and decentralised
More informationDHX Heat Exchanger. A new solution to heat transfer
DHX Heat Exchanger A new solution to heat transfer Sterile, efficient and modular The Thermo Scientific DHX Heat Exchanger is a modular system that employs a plate-and-frame concept, using a single-use
More informationOn-Site GMP Training GMP COMPLIANCE TECHNICAL
PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program
More informationManaging Your Environmental Isolates
Managing Your Environmental Isolates Good Testing Practices Good practice includes the periodic challenge of media with low levels of organisms. This includes USP indicator organisms as well as normal
More informationCGMP for Phase 1 INDs
CGMP for Phase 1 INDs Laurie P. Norwood Deputy Director Division of Manufacturing and Product Quality Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research 1 Overview
More informationGUIDE TO INSPECTIONS OF STERILE DRUG SUBSTANCE MANUFACTURERS
GUIDE TO INSPECTIONS OF STERILE DRUG SUBSTANCE MANUFACTURERS Note: This document is reference material for investigators and other FDA personnel. The document does not bind FDA, and does no confer any
More informationABL Europe s GMP manufacturing facility for viral vector production
ABL Europe s GMP manufacturing facility for viral vector production New Production Capacity for Viral Vectors Success Story ABL Europe GMP manufacturing of viral vectors from non-adherent cell cultures
More informationEnhancing Vaccine Development and Production
Enhancing Vaccine Development and Production Efficient Centrifuge Systems for Vaccine Development and Production Avanti JXN-26 The increasing ability of vaccines to impact quality of life is fueling demand
More informationWater Based Critical Utilities. RO, WFI, and Steam
Water Based Critical Utilities RO, WFI, and Steam The bottom of the iceberg that makes a plant run! Brian Hagopian, CPIP Chemist and President Clear Water Consulting, Inc brian@clear-water-consulting.com
More informationGeneral European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT
General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (16) 86 R2 MANAGEMENT OF ENVIRONMENTAL CONDITIONS Full document title and reference Document type Management of Environmental
More informationPMDA Perspective: Regulatory Updates on Process Validation Standard
CMC Strategy Forum Japan 2014 Tokyo, Japan, December 8-9, 2014 PMDA Perspective: Regulatory Updates on Validation Standard Kazunobu Oyama, PhD Office of Cellular and Tissue-based Products PMDA, Japan Disclaimer:
More informationWhitepaper BMS and Process Historian Validation Strategy
Whitepaper BMS and Process Historian Validation Strategy I N D U S T R Y I N S I G H T S Norman A. Goldschmidt Principal, VP Engineering www.geieng.com I N D U S T R Y I N S I G H T S Genesis periodically
More informationA.1 Contents file 4 to 5 A.1 (1)
Contents file 4 to 5 Contents file 4 to 5 A Information Contents file 4 to 5 A.2 Index file 4 to 5 A.3 List of Abbreviations A.4 Glossary A.5 Adress-Register A.6 References B Japanese Regulations B.1 MHW
More informationEuropean Guideline for Virus Safety Evaluation of Clinical Trial Material
Plasma Product Biotechnology Meeting, May 8 12, 2007 European Guideline for Virus Safety Evaluation of Clinical Trial Material Dr. Hannelore Willkommen Vice President Regulatory Affairs, NewLab Bioquality
More informationEU and FDA GMP Regulations: Overview and Comparison
THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational
More informationAvoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS
Avoid recurrent microbial contamination using trending of historical data El Azab Walid Technical Service Manager STERIS Agenda Factors influencing the cleaning and disinfection performance Recurring microbial
More informationDisinfectant Qualification A Multifaceted Study
Disinfectant Qualification A Multifaceted Study In this article, Ziva Abraham, Microrite, Inc., gives us a brief overview of the disinfectant qualification study process. An effective cleaning and disinfection
More informationWHEN, WHY AND HOW TO OUTSOURCE BIOMANUFACTURING: THE ROLE OF SINGLE USE TECHNOLOGIES
WHEN, WHY AND HOW TO OUTSOURCE BIOMANUFACTURING: THE ROLE OF SINGLE USE TECHNOLOGIES John Coyne Sr. Manager: Bioprocessing Research and Development Manufacturing Pfizer, Inc. 23 Years Industry Experience,
More informationTECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT Q12
INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE TECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT Q12 ANNEX Draft
More informationMicrobiology Research Associates
2017 Microbiology Research Associates List of Services www.mra-bact.com 33 Nagog Park Acton, MA 01720 978.263.2624 Page 1 of 11 Microbiology Tests Pharma/Biotech/Medical Devices Time From Sample Receipt
More informationTable of Contents. Presented by
Table of Contents Presented by HighTech Business Decisions 3150 Almaden Expressway, Suite 222, San Jose, CA 95118 Tel: (408) 978-1035 Fax: (408) 978-8925 www.hightechdecisions.com May 2017 TABLE OF CONTENTS
More informationAseptic Techniques. A. Objectives. B. Before coming to lab
Aseptic Techniques A. Objectives Become familiar with 1. The ubiquity of microorganisms (see Note 1) 2. Aseptic techniques (see Note 2) 3. Standard methods for growing/observing microorganisms (see Note
More informationYour Goal is Zero Positives. So is Ours.
Data Sheet Your Goal is Zero Positives. So is Ours. Granulated and Ready-to-Use Culture Media for Secure Media Fill Trials When performing media fill trials, you shouldn t have to worry about culture media
More informationValidation Guide USTR 2114 (2) Validation Guide for Pall Emflon PFR Filter Cartridges
Validation Guide USTR 2114 (2) Validation Guide for Pall Emflon PFR Filter Cartridges CONTENTS Part I. Overview 4 1. Introduction 4 2. Summary of Conclusions 4 Part II. Studies on Removal Efficiency 6
More informationTests to Support Sterility Claim. Imtiaz Ahmed
Tests to Support Sterility Claim Imtiaz Ahmed Sterile Product As per TGO 77, a sterile product must comply with the requirements of the following tests: Sterility Test Bacterial Endotoxins Test Appendix
More informationTrends in Perfusion Bioreactors: Will Perfusion Be the Next Revolution in Bioprocessing? June 15, 2011 BioProcess International
Trends in Perfusion Bioreactors: Will Perfusion Be the Next Revolution in Bioprocessing? June 15, 2011 BioProcess International Single-use/disposable bioprocessing equipment has come to thoroughly dominate
More informationGMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel
GMP MANUAL GMP MANUAL 1 Pharmaceutical Quality System (PQS) 1.A Preface 1.B The road to a Pharmaceutical Quality System 1.C Introduction to the PQS 1.C.1 General requirements 1.C (1) 1.C.2 Documentation
More informationF1 1/10 R&D BIOREACTORS/FERMENTORS
F1 1/10 R&D BIOREACTORS/FERMENTORS THE COMPANY Bionet is a specialist in Bioprocesses Engineering. We provide equipment (Bioreactors, Cross-Flow Filtration Systems and Cleaning-In-Place Systems) and advanced
More informationOutsourcing and Partnering for Commercial Grade Manufacturing Frank Tufaro, Ph.D.
Outsourcing and Partnering for Commercial Grade Manufacturing Frank Tufaro, Ph.D. Should You Partner Manufacturing? $$$ versus Control 2 Ph. 1 Registration Trials Commercial Launch CMO CMO or Partner CMO
More informationChuck Reed at Weiler Engineering, Inc compares aseptic blow-fill-seal technology with traditional aseptic processing of pharmaceutical liquids
Manufacturing Aseptic Advances Chuck Reed at Weiler Engineering, Inc compares aseptic blow-fill-seal technology with traditional aseptic processing of pharmaceutical liquids Acknowledged by the FDA as
More informationICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management - Annexes
1 2 3 14 December 2017 EMA/CHMP/ICH/831751/2017 Committee for Medicinal Products for Human Use 4 5 6 7 ICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle
More informationWhen Quality Matters. Microbial Air Samplers: Selection Criteria in Biopharma Manufacturing. Celebrating Over 50 Years In Business!
When Quality Matters Celebrating Over 50 Years In Business! Microbial Air Samplers: Selection Criteria in Biopharma Manufacturing Rev. 1.0 (Jan 2016) 1 Doc No.: TN-160104-1 Printed: January 4, 2016 Copyright
More informationMabSelect PrismA. gelifesciences.com/bioprocess
is a next-generation Protein A chromatography resin that offers significantly enhanced alkaline stability and binding capacity for improved process economy in monoclonal antibody (mab) processing. The
More informationPharma&Biotech. ADC Process Transfer from a CMO Perspective: How to Make a Collaboration Successful
Pharma&Biotech ADC Process Transfer from a CMO Perspective: How to Make a Collaboration Successful Additional Information and Disclaimer Lonza Group Ltd has its headquarters in Basel, Switzerland, and
More informationAdsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media. Dr. Robert Conway, Ph.D.
Adsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media Dr. Robert Conway, Ph.D. Depth Filter Cartridge Construction Zeta Plus Media Materials of Construction
More informationOperational & Economic Evaluation of Integrated Continuous Biomanufacturing Strategies for Clinical & Commercial mab Production
UCL Decisional Tools Research Operational & Economic Evaluation of Integrated Continuous Biomanufacturing Strategies for Clinical & Commercial mab Production Suzanne Farid PhD CEng FIChemE Reader (Associate
More informationClare Simpson 21 st November Content courtesy of Steve Jones, Paul Illot, Bert Frohlich, Thomas Ryll Biopharm Services
Modelling a technology roadmap for acceleration of global industry innovation Presentation to Wales Life Science Hub, Health Economics Special Interest Group Clare Simpson 21 st November 2016 Content courtesy
More informationEntry Level Assessment Blueprint Biotechnology
Entry Level Assessment Blueprint Biotechnology Test Code: 4075 / Version: 01 Specific Competencies and Skills Tested in this Assessment: Work Habits Demonstrate professional work habits Demonstrate the
More informationInspection Checklist for NIH BL3 Laboratories (7 CFR 331; 9 CFR 121; 42 CFR 73; NIH Guidelines)
12(a) 12(a) 12(b) 12 (c)(3) An individual or entity required to register under this part must develop and implement a written biosafety plan that is commensurate with the risk of the agent or toxin, given
More informationCell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products
Cell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products Founded in 96, Eurofins Lancaster Laboratories is a global leader in comprehensive laboratory services enabling
More informationNovel Technologies in Plasma Fractionation. Dieter Fassnacht
Novel Technologies in Plasma Fractionation Dieter Fassnacht Agenda Grifols Overview Grifols Engineering Innovations in - Pooling - Fractionation - Filling Developing new technologies to provide innovative
More information